We have identified marked sex-related differences in microglial activation, morphology, metabolism and function in APP/PS1 mice and we propose that these linked changes contribute to the more marked amyloid pathology, reduced neuroprotection and more profound cognitive impairment in females. Here, PSEN1 is linked to amyloidosis.